Assessment of Neutralising Activity of Colostrum-Derived, Polyclonal, Bovine Antibodies: Use of the J774A.1 Anthrax Lethal Toxin Cytototoxity Assay
Abstract
Bacillus anthracis lethal toxin is believed to play an important role in anthrax pathogenesis. Published reports have suggested that antibody therapies with specificity against lethal toxin may improve survival in animal models. Macrophage cell lines such as J774A.1 provide fast, convenient models to measure LeTx activity. Here, we report the use of the J774A.1 cytotoxicity assay to assess the neutralising activity of colostrum-derived, polyclonal, bovine antibodies. Antibodies against lethal factor and protective antigen were found to protect macrophages from lethal toxin, and should be investigated further as a treatment for anthrax.
Document Details
- Document Type
- Technical Report
- Publication Date
- Dec 01, 2005
- Accession Number
- ADA449511
Entities
People
- Alison K. Pickering
- Malcolm R. Alderton
Organizations
- Defence Science and Technology Group